Sessionspan
A between-session continuity layer that rides on top of any employer EAP — supervised AI check-ins keep care going between the plan's handful of annual sessions, track symptom trajectory, and bill the employer per verified engagement.
A mid-market employer buys an EAP, and every employee who uses it gets the same hard wall: roughly six counseling sessions a year, then nothing. The hardest weeks for someone in care are the ones between sessions and after the sessions run out — exactly where the benefit goes dark. Benefits leaders see the engagement numbers crater after the allotment is spent and have no way to extend care without buying a second, redundant point solution. The cliff is the product gap, and nobody is filling it for the 100–2,000 FTE employer.
The benefits or HR lead at a mid-market employer (100–2,000 FTE) who already owns the EAP line item and personally fields the complaint that the benefit runs out right when people need it. They are buying an extension to a benefit they already pay for, not a net-new category to justify from zero.
The EAP cliff versus continuity of care is a genuine unresolved tension, and supervised per-engagement check-ins are a credible resolution neither side of the market offers today.
The cost floor, the live micropayment rail, and a dated regulatory cascade all landed recently — the enabling pieces are new, not hypothetical.
Three cross-reference mentions and seven connections, but the kin are mostly same-run siblings rather than independent corroboration.
Unusually well-evidenced for its batch: a dated regulatory cascade, named funding that validates the employer-pays model, and — confirmed for the first time this run — a sub-$1-per-session voice cost floor. The productive tension is real and specific: the EAP cliff versus continuity of care, resolved by clinician-supervised check-ins billed per verified engagement, which is something neither EAPs nor consumer AI chatbots resolve on their own.
ULTRA complexity with only one of six required capabilities externally verified, and per-engagement micropayment billing to employers is unproven B2B buyer behavior. Convergence is modest because most of its connected ideas are same-run siblings, and the structural reason EAP vendors can't follow down is inferred rather than evidenced. The defensibility has to come from the continuity corpus, not the technology.
Genesis doesn't invent in isolation — Sessionspan shares architecture with, or powers, these ideas.
Discussion
No comments yet — be the first to weigh in.